Acura Pharmaceuticals, Inc. (NASDAQ: ACUR)
April 5th, 2011 we released our published article, "TooNiceStocks Initiates Coverage on Acura Pharmaceuticals Inc. (NASDAQ: ACUR) Pending June 17th, 2011 FDA Decision with Elevated Interest". Our members were notified @ $3.70 and later ran to $4.99 rallying up to 34.86% ACUR's lead product acurox was granted a priority review with the Prescription Drug User Fee Act and to manufacture and market without having to file a new drug application. Read full report here.


